Monarch Biosciences

Monarch Biosciences is a company that develops a pipeline of products based on its proprietary thin-film nitinol (TFN) biomaterial. Its product, the Titan Flow Diverter, offers the occlusion of cerebral aneurysms. The second product in its pipeline, the Engineered Lymph Node (ELN), is a TFN-based device for local delivery of cell therapies treating solid tumors.